EBC-46 has the potential to revolutionise the treatment of solid tumour cancers in animals.
Accurate data on the rates of cancer (either incidence of new cases or overall prevalence in the population) in companion animals are difficult to obtain due to the lack of formal registries which gather population-based health statistics (e.g. population sizes and breed structure, longevity, neutering patterns, mortality rates and causes, etc).
Nonetheless, it is possible to make realistic estimates of the occurrence and epidemiology of different cancers in companion animals from survey data collected from university veterinary hospitals and large veterinary practices in the USA, Canada, UK and Australia.
In the table below the estimated annual number of new cases of cancer that are suitable for treatment with EBC-46 in dogs, cats and horses can be found. This data clearly identifies cancer as a major disease afflicting millions of companion animals worldwide.
Incidence of cancer in animals